SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems is experiencing a surge in momentum following a wave of bullish analyst initiations that highlighted its specialized AI hardware and strategic partnerships with major cloud providers. While investors are closely watching for the company's inaugural earnings report and upcoming share lock-up expirations, the community is actively debating whether the stock's recent price action is driven by genuine long-term inference demand or speculative IPO hype.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust is experiencing significant volatility driven by intense speculation surrounding a potential Iran peace deal and shifting expectations for Federal Reserve policy. Investors are actively debating whether this movement represents a sustainable bottom or a temporary relief rally as they weigh conflicting reports on geopolitical resolutions and the broader economic outlook.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is experiencing increased market volatility and downward pressure following multiple analyst downgrades ahead of upcoming earnings. Despite this, the community remains actively divided, with many long-term investors viewing the pullback as a buying opportunity fueled by anticipation for the World Cup and confidence in the company's long-term brand strength and share buyback strategy.

FedEx Corp. is a holding company, which engages in the provision of transportation, e-commerce, business services, and business solutions. It operates through the following segments: FedEx Express, FedEx Freight, Corporate, Other, and Eliminations. The FedEx Express segment offers transportation and delivery services. The FedEx Freight segment refers to freight transportation services to business and residences. The FedEx Services segment includes sales, marketing, information technology, communications, customer service, technical support, billing and collection services, and certain back-office functions that support the company's operating segments. The Corporate, Other, and Eliminations segment is involved in the corporate headquarters costs for executive officers and certain legal and finance functions, as well as certain other costs and credits not attributed to the firm's core business. The company was founded by Frederick Wallace Smith on June 18, 1971, and is headquartered in Memphis, TN.

Fedex Corp

FedEx shares are experiencing significant volatility following a mixed earnings report where a notable revenue and EPS beat was overshadowed by underwhelming fiscal 2027 guidance and concerns regarding post-spin-off performance. The community is sharply divided, with some investors aggressively betting on a short-term rebound driven by the company's $1 billion buyback program and free cash flow generation, while others remain skeptical, citing macroeconomic headwinds and the stock's recent cooling trend.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently facing intense selling pressure and a technical breakdown, with the market decoupling the company's robust operational growth, including major U.S. Army and Zeta partnership wins, from its stock price. While the community is sharply divided between those viewing the pullback as a generational entry point for a long-term AI play and others anticipating deeper re-pricing due to extreme valuation multiples and broader sector volatility, many traders are closely watching how the stock behaves around critical support levels to determine if the current downward momentum is approaching exhaustion.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending due to strong institutional demand and significant earnings momentum, with the stock recently breaking out of a long-term consolidation range to hit fresh 52-week highs. Investors are actively discussing the company's improved unit economics and margin expansion, viewing it as a high-conviction growth play that is finally gaining market recognition.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is currently experiencing high volatility driven by a intense battle between retail bulls, who are aggressively accumulating shares and citing long-term potential in agentic AI, and short sellers, who are keeping downward pressure on the stock. Community members are actively debating the company's path to profitability and acquisition strategy, while remaining fixated on technical levels and potential catalysts that could trigger a squeeze.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing significant volatility as investors weigh a major sell-off driven by South Korean regulatory concerns against anticipation for an upcoming earnings release. The community remains deeply divided, with bulls pointing to strong AI demand and institutional price target hikes as reasons to buy the dip, while bears argue the stock is overextended and susceptible to a post-earnings correction.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the Consumer and Business segments. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon is trending as the market reacts to the news of its removal from the Dow Jones Industrial Average, with many investors debating the company's long-term utility as a defensive dividend play amidst shifting industrial leadership. Community sentiment remains polarized, with some focused on the technical pivot toward AI-integrated infrastructure, while others highlight dividend stability as a hedge against broader market volatility.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm, through its storage cloud platform, provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng and Brian Wilson in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblaze is seeing a significant structural re-rating following a $335 million, 5-year storage deal with CoreWeave, signaling its growing role in the AI infrastructure ecosystem. The stock is currently experiencing high-volatility price discovery as the community debates the transformative revenue visibility against speculation regarding potential future equity offerings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OTLK Stock Up 35% as FDA Accepts Resubmitted Eye Drug BLA for Review

Outlook Therapeutics stock surges 35% after the FDA accepts the resubmitted Lytenava BLA for wet AMD for review, setting a July 29, 2026, decision date.

Outlook Therapeutics Eye Drug Review Returns To FDA For Fourth Time

Outlook Therapeutics shares rose after the FDA accepted its resubmitted LYTENAVA BLA and set a July 2026 target action date.read more...

OTLK Stock Soars 28% After FDA Sets July Date For Lytenava Decision

Equity

The agency will now decide whether to approve the drug by July 29, 2026.

OTLK Stock Surges On FDA Lytenava Application Resubmission After Successful Appeal  

A decision on the resubmitted application is expected within 60 days of the FDA’s receipt of it, the company said.


OTLK Stock Rocket Nearly 140%: Lytenava Dispute Resolution With FDA Pushes Stock On Track For Best Week On Record

Outlook Therapeutics wins appeal following formal dispute resolution process for LYTENAVA.

Why RDW, TE, OTLK Stocks Posted Double-Digit Gains On Tuesday

Redwire, T1 Energy, and Outlook Therapeutics shares soared due to broad sectoral optimism, strong institutional backing, and positive company developments, respectively. 

Traders Rush into AI, Biotech, and Emerging Tech

Momentum traders are aggressively rotating into AI infrastructure, biotech catalysts, blockchain exposure, and emerging technology plays as speculative appetite continues heating up across small-cap and high-growth sectors. $KBLB, $OTLK, $PHGE, $UZX, $QTEK $ARTL, $VCIG, $YMAT, $NCRA

Outlook Therapeutics Stock Climbs 38% After Winning FDA Appeal For NAMD Therapy

(RTTNews) - Shares of Outlook Therapeutics, Inc. (OTLK) are climbing about 38 percent in Tuesday morning trading after the company announced that the U.S. FDA has granted its appeal following completion of the Formal Dispute Resolution process for ONS-5010/LYTENAVA, its investiga...

OTLK Stock Surges Over 50% Pre-Market, Breaches Key Technical Milestone – What’s Behind This Massive Rally?

The U.S. Food and Drug Administration granted Outlook Therapeutics its appeal following a formal dispute resolution process related to its eye disease drug Lytenava.

Oncobiologics, Inc. (OTLK) Reports Q2 Loss, Lags Revenue Estimates

Oncobiologics (OTLK) delivered earnings and revenue surprises of -33.33% and -97.09%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

This account has been verified as an official OTLK representative.

Verified Account

Outlook Therapeutics

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.

Outlook Therapeutics Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

Investors are buzzing as the 10-day NASDAQ compliance countdown nears completion, expected to trigger institutional inflows.

Anticipation is reaching a fever pitch for the July 29th FDA decision, with bulls betting on imminent approval.

Traders are closely watching price action and order book roadblocks as the stock eyes a push above the critical $2.00 level.

Bulls are relishing in the resilience against short sellers who have repeatedly failed to push the stock price down despite low volume.

Speculation remains high about potential acquisition interest post-approval, despite ongoing debates regarding management's commercialization strategy.

Feed

News

Sentiment

Earnings

Fundamentals

Info

OTLKOutlook Therapeutics Inc

Latest OTLK News